SEATTLE (AP) _ CTI BioPharma Corp. (CTIC) on Monday reported a loss of $10 million in its third quarter.
The Seattle-based company said it had a loss of 17 cents per share.
The biotechnology company posted revenue of $2.3 million in the period.
In the final minutes of trading on Monday, the company's shares hit 80 cents. A year ago, they were trading at $1.80.